1-4 which is characterized by new deficits in global cognition or executive function.

Vasilevskis, A.K. Shintani, K.G. Moons, S.K. Geevarghese, A. Canonico, R.O. Hopkins, G.R. Bernard, R.S. Dittus, and E.W. Ely for the BRAIN-ICU Study Investigators: Long-Term Cognitive Impairment after Important Illness Survivors of critical illness frequently have an extended and poorly understood form of cognitive dysfunction,1-4 which is characterized by new deficits in global cognition or executive function. This long-term cognitive impairment after vital illness could be a growing public medical condition, given the large numbers of acutely ill individuals being treated in intensive treatment units globally.5 Among older adults, cognitive decline is associated with institutionalization,6 hospitalization,7 and considerable annual societal costs.8,9 Yet little is well known about the epidemiology of long-term cognitive impairment after critical illness.Yet, only 12 % of individuals who were treated with a transplant between 2004 and 2008 in U.S. Organizations were over age 60 and a previous study suggested that only 26 % of individuals with acute myeloid leukemia had been treated with a transplant, according to results reported by the guts of International Bloodstream and Marrow Transplantation Research. ‘These statistics clearly highlight the reluctance of suppliers in offering allogeneic stem cell transplantation to the elderly,’ Sorror said. ‘Small is known about the reasons behind the reduced referral rate of old individuals to transplant or how mini-transplant outcomes evaluate to those of typical therapies. We are initiating a multicenter study made to follow patients from the proper time of medical diagnosis to answer both queries.’ Sorror said.